Croda International (LON:CRDA) Stock: Insider Stephen Oxley Buys 5 Shares

Croda International Plc (LON:CRDA) insider Stephen Oxley acquired 5 shares of the stock in a transaction dated Monday, October 12th. The stock was bought at an average cost of GBX 3,388 per share, with a total value of £169.40.

Stephen Oxley also recently made the following trade(s):

• On Thursday, September 10th, Stephen Oxley bought 4 shares of Croda International stock. The stock was bought at an average price of GBX 3,218 per share, for a total transaction of £128.72.
• On Monday, August 10th, Stephen Oxley bought 5 shares of Croda International stock. The stock was bought at an average price of GBX 3,292 per share, for a total transaction of £164.60.
• On Monday, August 3rd, Stephen Oxley sold 1,339 shares of Croda International stock. The shares were sold at an average price of GBX 3,214, for a total value of £43,035.46.

Croda International Stock Up 2.9%

Shares of LON:CRDA traded up GBX 100 during mid-day trading on Tuesday, hitting GBX 3,517. 463,121 shares of the company traded hands, compared to its average volume of 4,424,601. The stock has a 50-day moving average price of GBX 3,295.78 and a two-hundred day moving average price of GBX 3,075.73. Croda International Plc has a 12-month low of GBX 2,488 and a 12-month high of GBX 3,543. The stock has a market cap of £4.90 billion, a P/E ratio of 61.81, a P/E/G ratio of 1.40 and a beta of 0.92. The company has a current ratio of 2.57, a quick ratio of 2.25 and a debt-to-equity ratio of 36.06.

Croda International (LON:CRDA) last released its quarterly earnings results on Tuesday, July 28th. The company reported GBX 72.20 EPS for the quarter. Croda International had a return on equity of 3.65% and a net margin of 4.61%. On average, equities research analysts forecast that Croda International Plc will post 181.83 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CRDA. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a GBX 3,300 target price on shares of Croda International in a report on Wednesday, July 29th. Berenberg Bank restated a “buy” rating and set a GBX 3,600 price target on shares of Croda International in a report on Wednesday, July 29th. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 4,000 price objective on shares of Croda International in a research report on Friday, September 25th. Finally, Citigroup upped their price objective on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the stock a “neutral” rating in a research report on Wednesday, July 29th. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of GBX 3,490.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.